EUROFINS SCIENT Other Current Assets 2018-2024 | ERFSF

EUROFINS SCIENT other current assets for the quarter ending December 31, 2024 were $0.539B, a 16.51% decline year-over-year.

  • EUROFINS SCIENT other current assets for 2024 were $0.331B, a 0.51% decline from 2023.
  • EUROFINS SCIENT other current assets for 2023 were $0.333B, a 9.6% increase from 2022.
  • EUROFINS SCIENT other current assets for 2022 were $0.304B, a 23.88% decline from 2021.

EUROFINS SCIENT Other Current Assets 2018-2024 | ERFSF

  • EUROFINS SCIENT other current assets for 2024 were $0.331B, a 0.51% decline from 2023.
  • EUROFINS SCIENT other current assets for 2023 were $0.333B, a 9.6% increase from 2022.
  • EUROFINS SCIENT other current assets for 2022 were $0.304B, a 23.88% decline from 2021.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$141.7B
CVS Health (CVS)$78.2B
Elevance Health (ELV)$66.8B
Cencora (COR)$56.9B
DiDi Global (DIDIY)$28B
Labcorp Holdings (LH)$21B
Natera (NTRA)$18.8B
BioMerieux (BMXMF)$16B
ICON (ICLR)$13.6B
CochLear (CHEOY)$13.5B
Solventum (SOLV)$12.9B
Medpace Holdings (MEDP)$12.3B
Revvity (RVTY)$11.7B
Viatris (VTRS)$11B
Avantor (AVTR)$9.3B
Sonic Healthcare (SKHHY)$9.1B
HealthEquity (HQY)$8.4B
Charles River Laboratories (CRL)$8.2B
Caris Life Sciences,�Inc (CAI)$7.6B
Amplifon S.p.A (AMFPF)$5.4B
Bausch + Lomb (BLCO)$5B
BrightSpring Health Services (BTSG)$3.7B
Sotera Health (SHC)$3.4B
Surgery Partners (SGRY)$2.8B
Organon (OGN)$2.6B
Concentras Parent (CON)$2.6B
Alignment Healthcare (ALHC)$2.5B
GeneDx Holdings (WGS)$2.4B
Progyny (PGNY)$2B
PACS (PACS)$1.8B